Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Urologia Internationalis|August 15, 2012
Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysisShimiao Zhu, Hui Zhang, Yang Tang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 23, 2013
Two-gene expression ratio as predictor for breast cancer treated with tamoxifen: evidence from meta-analysisLin Zhao, Shimiao Zhu, Ying Gao, et al.
Molecular Biology Reports|September 23, 2011
DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studiesShimiao Zhu, Hui Zhang, Yang Tang, et al.
The Journal of Urology|September 27, 2012
Risk factors and prevention of inguinal hernia after radical prostatectomy: a systematic review and meta-analysisShimiao Zhu, Hui Zhang, Linguo Xie, et al.
Bioengineered|June 12, 2021
Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder CancerGaoteng Lin, Jianwei Zhang, Yuqi Wu, et al.
The Prostate|June 19, 2013
Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cellsSimeng Wen, Zhiqun Shang, Shimiao Zhu, et al.
Plos One|October 17, 2013
A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participantsNing Jiang, Shimiao Zhu, Jing Chen, et al.
Plos One|December 9, 2017
Correction: A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 ParticipantsNing Jiang, Shimiao Zhu, Jing Chen, et al.
Cancer Reports (Hoboken, N.J.)|June 22, 2023
Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymalHaotian Wei, Zhaochen Li, Yang Zhao, et al.
Cancer Letters|December 11, 2012
HoxB3 promotes prostate cancer cell progression by transactivating CDCA3Jing Chen, Shimiao Zhu, Ning Jiang, et al.
Pageof 5